Influenza, SARS-CoV-2, and RSV: 4 drug makers have all 3 viruses targeted for vaccines, alone and in combination. Click through the flash-card update.
Flu season 2022-23 sits on the horizon and for the fourth consecutive year will be complicated by cocirculation of the SARS-CoV-2 virus. An increasing concern, too, is the presence of respiratory syncytial virus which while typical for the season has affected more older adults and affected them more severely as pandemic precautions have shifted.
Four manufacturers have all 3 viruses targeted for vaccines, alone and in combination. Here’s an at-a-glance update on what to look for.